Diabetes: statins, fibrates, or both?

Farnier, M; Picard, S

Farnier, M; Picard, S.

Affiliation

Farnier M; Point Medical, Rond-Point de la Nation, Dijon, F-21000, France. mfarnier@ipac.fr

Curr Atheroscler Rep ; 3(1): 19-28, 2001 Jan.

Article in En | MEDLINE | ID: mdl-11123844

Subject(s)

Diabetes Mellitus, Type 2/complications; Hyperlipidemias/etiology; Hyperlipidemias/prevention & control; Clinical Trials as Topic; Clofibric Acid/therapeutic use; Diabetes Mellitus, Type 2/drug therapy; Diabetes Mellitus, Type 2/prevention & control; Drug Therapy, Combination; Humans; Hyperlipidemias/drug therapy; Hypolipidemic Agents/therapeutic use; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Health context: 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Hyperlipidemias Limits: Humans Language: En Journal: Curr Atheroscler Rep Year: 2001 Document type: Article

Search on Google

XML

PubMed Links